Dr. Norman P. Gebrosky, MD

Dr. Gebrosky practices at Westmoreland Hospital in Greensburg, Pennsylvania, part of West Virginia University Health System.

Dr. Gebrosky's NPI, 1659476224, was assigned on September 14, 2006. Dr. Gebrosky graduated from University of Pittsburgh School of Medicine in 1990. Dr. Gebrosky holds Pennsylvania license MD058568L.

Dr. Gebrosky's primary practice is Westmoreland Hospital, at 532 West Pittsburgh Street, Greensburg, PA 15601 in Westmoreland County. The practice phone is (724) 832-4000.

Dr. Gebrosky's primary practice is Westmoreland Hospital in Greensburg, Pennsylvania, part of West Virginia University Health System. Dr. Gebrosky is also affiliated with UPMC Magee-Womens Hospital. The medical group on file is Excela Health Medical Group (EHMG). Dmand AI also links Dr. Gebrosky to 2 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gebrosky practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Gebrosky's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Gebrosky is board certified in urology by the American Board of Urology. Dmand AI has Dr. Gebrosky's licenses on file in 2 states: Pennsylvania and West Virginia.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney removal surgery, kidney stone disease, prostate cancer and prostate inflammation or infection among the conditions Dr. Gebrosky treats.

CMS data shows 7,429 Medicare services from Dr. Gebrosky across 28 procedure codes in 2024, for 764 Medicare patients. Medicare paid $205,477 for them.

CMS counts 764 Medicare patients who saw Dr. Gebrosky in 2024. The largest group is 65 to 74, with 384 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gebrosky's median patient age at 73, with 20% women.

In 2024, Dr. Gebrosky wrote 1,258 Medicare Part D claims for 557 patients. 90% of them were for generic drugs. CMS names the drug for 1,090 of them, across 19 drugs with 11 or more claims each, at $632,863 in total drug cost. In 2023, CMS named 952 claims across 17 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gebrosky for performance year 2024, reported as part of a group. Dr. Gebrosky accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Gebrosky.

CMS Open Payments shows 533 general payments to Dr. Gebrosky from 56 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 83% of the total. Astellas Pharma US Inc paid the most, $2,010.

Dmand AI lists 1 award for Dr. Gebrosky.

Dr. Gebrosky graduated from University of Pittsburgh School of Medicine in 1990.

Dr. Gebrosky is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.